Page last updated: 2024-11-12

cypate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cypate: a fluorescent dye; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10963571
CHEMBL ID2071606
MeSH IDM000614051

Synonyms (8)

Synonym
cypate
CHEMBL2071606
GRAVJJAQKJDGPM-UHFFFAOYSA-N
3-[(2e)-2-[(2e,4e,6e)-7-[3-(2-carboxyethyl)-1,1-dimethylbenzo[e]indol-3-ium-2-yl]hepta-2,4,6-trienylidene]-1,1-dimethylbenzo[e]indol-3-yl]propanoic acid;bromide
95837-47-1
EX-A4740
E86095
317809-26-0

Research Excerpts

Overview

Cypate is an organic material with tumor treatment function, which has photothermal effect.

ExcerptReferenceRelevance
"Cypate is an organic material with tumor treatment function, which has photothermal effect. "( Preparation of Composite Cypate Nanoparticles and Its Application in the Treatment of Pediatric Bladder Tumors.
Bai, B; Chen, W; Lei, Y; Li, Z; Ma, H; Tao, H; Wang, L; Yang, P; Zhang, N, 2021
)
2.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID678143Binding affinity to integrin alphavbeta3 in human A549 cells assessed as cellular uptake after 1 hr by NIR Fluorescence microscopy analysis2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Near-infrared fluorescent divalent RGD ligand for integrin αvβ₃-targeted optical imaging.
AID678144Binding affinity to integrin alphavbeta3 in human A549 cells assessed as cellular uptake after 6 hrs by NIR Fluorescence microscopy analysis2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Near-infrared fluorescent divalent RGD ligand for integrin αvβ₃-targeted optical imaging.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's16 (66.67)24.3611
2020's8 (33.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.06 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]